Tool
Growth Programme
Product
Blue Bio Value
SDG
3: Good Health and Well-being
Website
Exogenus Therapeutics
Exogenus Therapeutics develops innovative exosome-based therapies targeting inflammatory and autoimmune diseases, including severe lung inflammation caused by COVID-19.
Access